Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Century Therapeutics
Biotech
Cell therapy biotech axes cancer trial, turns to autoimmune
Cell therapy biotech Century is discontinuing a phase 1 cancer study to turn its focus toward autoimmune diseases.
Gabrielle Masson
Mar 19, 2025 5:35pm
Bristol Myers culls cell therapy deals with 2 biotechs
Dec 16, 2024 11:19am
Acadia brings BMS vet on board as CEO—Chutes & Ladders
Sep 27, 2024 8:30am
Double autoimmune acquisitions as Century, Eliem pick up peers
Apr 11, 2024 9:06am
Gene editor Metagenomi adds C-suite execs—Chutes & Ladders
Nov 10, 2023 9:30am
Century, Elevation to cut assets, staff; Nabriva winds down
Jan 6, 2023 10:40am
